Q4 2023 Syros Pharmaceuticals Inc Earnings Call Transcript
Good morning, and welcome to Seres Pharmaceuticals' Fourth Quarter and Full Year 2023 financial results conference call.
At this time, all participants are in a listen only mode. This call is being webcast live on the Investors and Media section of CAE's website at www.cirrus.com. Please be advised that today's call is being recorded. And at this time, I would like to turn the call over to Karen minority, Director of Investor Relations and Corporate Communications.
Yes, thank you.
&
This morning we issued a press release announcing our fourth quarter and full year 2023 financial results. The full release is available on the Investor & Media section of the Cirrus this website at www.cirrus.com. We will begin the call with prepared remarks by timely team, our Chief Executive Officer, Dr. David Roth
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |